Unexpected Splenic Uptake of 99mTc-HMDP on Bone Scintigraphy in an Adult Patient with Sickle Cell Disease: A Diagnostic Pitfall and Pathophysiological Correlation

Fuente: Zenodo
Saved in:
Bibliographic Details
Main Authors: A. Muhoza, E. Kpekpeou, G. Rossito, M. Chaoui, A. El Boukhrissi, N. Ismaili Alaoui, N. Andrian
Format: Recurso digital
Published: Zenodo 2026
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1866901081114542080
author A. Muhoza
E. Kpekpeou
G. Rossito
M. Chaoui
A. El Boukhrissi
N. Ismaili Alaoui
N. Andrian
author_facet A. Muhoza
E. Kpekpeou
G. Rossito
M. Chaoui
A. El Boukhrissi
N. Ismaili Alaoui
N. Andrian
contents <h1><em><span>Abstract</span></em></h1> <p><em><span>Bone scintigraphy using 99mTc‑hydroxymethylene diphosphonate (HMDP) is routinely employed to assess bone metabolism, usually without visualization of extraosseous soft tissues apart from the urinary tract. Splenic uptake of this tracer is unusual, particularly in adult patients with sickle cell disease, because functional or anatomical asplenia is commonly observed as a consequence of repeated splenic infarctions. </span></em></p> <p><em><span>We report the case of a 57‑year‑old woman with long‑standing sickle cell disease, a history of multiple blood transfusions, and a spleen not visualized on recent ultrasound. During bone scintigraphy performed for right hip pain, faint but definite splenic uptake of 99mTc‑HMDP was observed, together with nonspecific visceral opacifications and bone changes consistent with sickle‑related infarctions. The absence of recent contrast‑enhanced cross‑sectional imaging limited the direct assessment of calcifications. This splenic uptake was interpreted as secondary to dystrophic fibro‑calcific remodeling after infarction, promoted by chronic iron overload and chelation therapy. Splenic visualization of 99mTc‑HMDP in an adult patient with sickle cell disease must be interpreted with caution and should not be equated with residual splenic function. Clinical correlation and multimodality imaging are essential. This finding represents a diagnostic pitfall and should not be misinterpreted as residual splenic function. Careful clinical correlation and multimodal imaging assessment are essential.</span></em></p> <p><em><span> </span></em></p> <p><strong><em><span>Keywords:</span></em></strong><em><span> Sickle cell disease, Splenic uptake, Bone scintigraphy, 99mTc‑HMDP. </span></em></p>
format Recurso digital
id zenodo_https___doi_org_10_5281_zenodo_19355837
institution Zenodo
language
publishDate 2026
publisher Zenodo
record_format zenodo
spellingShingle Unexpected Splenic Uptake of 99mTc-HMDP on Bone Scintigraphy in an Adult Patient with Sickle Cell Disease: A Diagnostic Pitfall and Pathophysiological Correlation
A. Muhoza
E. Kpekpeou
G. Rossito
M. Chaoui
A. El Boukhrissi
N. Ismaili Alaoui
N. Andrian
<h1><em><span>Abstract</span></em></h1> <p><em><span>Bone scintigraphy using 99mTc‑hydroxymethylene diphosphonate (HMDP) is routinely employed to assess bone metabolism, usually without visualization of extraosseous soft tissues apart from the urinary tract. Splenic uptake of this tracer is unusual, particularly in adult patients with sickle cell disease, because functional or anatomical asplenia is commonly observed as a consequence of repeated splenic infarctions. </span></em></p> <p><em><span>We report the case of a 57‑year‑old woman with long‑standing sickle cell disease, a history of multiple blood transfusions, and a spleen not visualized on recent ultrasound. During bone scintigraphy performed for right hip pain, faint but definite splenic uptake of 99mTc‑HMDP was observed, together with nonspecific visceral opacifications and bone changes consistent with sickle‑related infarctions. The absence of recent contrast‑enhanced cross‑sectional imaging limited the direct assessment of calcifications. This splenic uptake was interpreted as secondary to dystrophic fibro‑calcific remodeling after infarction, promoted by chronic iron overload and chelation therapy. Splenic visualization of 99mTc‑HMDP in an adult patient with sickle cell disease must be interpreted with caution and should not be equated with residual splenic function. Clinical correlation and multimodality imaging are essential. This finding represents a diagnostic pitfall and should not be misinterpreted as residual splenic function. Careful clinical correlation and multimodal imaging assessment are essential.</span></em></p> <p><em><span> </span></em></p> <p><strong><em><span>Keywords:</span></em></strong><em><span> Sickle cell disease, Splenic uptake, Bone scintigraphy, 99mTc‑HMDP. </span></em></p>
title Unexpected Splenic Uptake of 99mTc-HMDP on Bone Scintigraphy in an Adult Patient with Sickle Cell Disease: A Diagnostic Pitfall and Pathophysiological Correlation
url https://doi.org/10.5281/zenodo.19355837